In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Infectious Diseases

• Publication date

  2005-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/429697PMID 15838796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

  2006cited by this paper
• Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

  2004cited by this paper
• Antiretroviral nucleoside and nucleotide analogues and mitochondria.

  2004cited by this paper
• Treatment for Adult HIV Infection 2004 Recommendations of the International AIDS Society-USA Panel

  2004cited by this paper
• No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

  2004cited by this paper
• Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy

  2003influential reference
• Combination antiretroviral therapy and the risk of myocardial infarction

  2003cited by this paper
• Depletion of mitochondrial DNA in HIV‐1‐infected patients and its amelioration by antiretroviral therapy

  2003cited by this paper
• Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective

  2003cited by this paper
• Combination antiretroviral therapy and the risk of myocardial infarction.

  2003cited by this paper
• Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

  2003cited by this paper
• Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort

  2003cited by this paper
• Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy

  2003influential reference
• Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

  2003cited by this paper
• Cytochrome oxidase in health and disease.

  2002cited by this paper
• Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy

  2002cited by this paper
• Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.

  2002cited by this paper
• Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.

  2002cited by this paper
• The role of PPAR-γ in macrophage differentiation and cholesterol uptake

  2001cited by this paper
• Regulation of leptin production.

  2001cited by this paper
• The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

  2001cited by this paper
• HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia

  2001cited by this paper
• Regulation of Leptin Production

  2001cited by this paper
• Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia.

  2001cited by this paper
• Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

  2001cited by this paper
• Regulation of adipogenesis and energy balance by PPARγ and PGC-1

  2000cited by this paper
• Dual regulation of leptin secretion: intracellular energy and calcium dependence of regulated pathway.

  2000cited by this paper
• The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes

  2000cited by this paper
• Regulation of adipogenesis and energy balance by PPARgamma and PGC-1.

  2000cited by this paper
• The role of lipoprotein lipase in adipose tissue development and metabolism

  2000influential reference
• Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

  2000cited by this paper
• Suppression of Preadipocyte Differentiation and Promotion of Adipocyte Death by HIV Protease Inhibitors*

  2000cited by this paper
• Autonomous Regulation in Mammalian Mitochondrial DNA Transcription

  1999influential reference
• Mechanisms of human mitochondrial DNA maintenance: the determining role of primary sequence and length over function.

  1999cited by this paper
• Visceral abdominal-fat accumulation associated with use of indinavir.

  1998cited by this paper
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

  1998cited by this paper
• Mitochondrial DNA polymerase gamma is expressed and translated in the absence of mitochondrial DNA maintenance and replication.

  1996cited by this paper
• Mitochondrial toxicity of antiviral drugs

  1995cited by this paper
• Effects of cold environment on mitochondrial genome expression in the rat: evidence for a tissue-specific increase in the liver, independent of changes in mitochondrial gene abundance.

  1993cited by this paper
• RTG1 and RTG2: two yeast genes required for a novel path of communication from mitochondria to the nucleus.

  1993cited by this paper
• Mitochondrial myopathy caused by long-term zidovudine therapy.

  1990cited by this paper
• Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle.

  1986cited by this paper
• FAST TRACK: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome

  year unknowncited by this paper

• The antiretroviral drug emtricitabine increases kynurenine : tryptophan ratio, aryl hydrocarbon receptor activation, and cellular senescence in female mice.

  2025cites this paper
• Overview of methods that determine mitochondrial function in human disease

  2025cites this paper
• High-risk alcohol consumption is associated with mitochondrial damage-associated molecular patterns in people living with HIV

  2025cites this paper
• Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemia

  2025cites this paper
• Circulating mitochondrial long non-coding 7S RNA in primary health care patients with depression/anxiety.

  2023cites this paper
• Serum Interleukin-6 and Weight loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.

  2022cites this paper
• Comparison of the Effects of Three Dual-Nucleos(t)ide Reverse Transcriptase Inhibitor Backbones on Placenta Mitochondria Toxicity and Oxidative Stress Using a Mouse Pregnancy Model

  2022cites this paper
• A Modern Genotoxicity Testing Paradigm: Integration of the High-Throughput CometChip® and the TGx-DDI Transcriptomic Biomarker in Human HepaRG™ Cell Cultures

  2021cites this paper
• Green Tea (Camellia sinensis) Ameliorate Non-alcoholic Fatty Liver Disease Induced by Highly Active Antiretroviral Therapy

  2021cites this paper
• Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients

  2020cites this paper
• Tenofovir alafenamide does not inhibit mitochondrial function and cholesterol biosynthesis in human T lymphoblastoid cell line.

  2020cites this paper
• Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers

  2019cites this paper
• DNA polymerase-γ hypothesis in nucleoside reverse transcriptase-induced mitochondrial toxicity revisited: A potentially protective role for citrus fruit-derived naringenin?

  2019cites this paper
• The footprints of mitochondrial impairment and cellular energy crisis in the pathogenesis of xenobiotics-induced nephrotoxicity, serum electrolytes imbalance, and Fanconi's syndrome: A comprehensive review.

  2019cites this paper
• Drug‐Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children

  2018cites this paper
• The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality

  2018cites this paper
• Lung function in HIV-infected children and adolescents

  2018cites this paper
• Prevalence of Lipodystrophy and Metabolic Syndrome at the Bertoua Day Hospital (East Region of Cameroon)

  2017cites this paper
• Mitochondrial T3 receptor and targets.

  2017cites this paper
• Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.

  2017cites this paper
• Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity

  2017cites this paper
• Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Beyond the polymerase-γ theory Production of ROS as a mode of NRTI-induced mitochondrial toxicity

  2017cites this paper
• Cardio-metabolic effects of anti-retroviral treatment in the Cape Winelands region of South Africa

  2016cites this paper
• sensitivity in HIV-lipodystrophy Depot-specific regulation of glucose uptake and insulin

  2016cites this paper
• Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin‐treated childhood acute lymphoblastic leukemia survivors

  2016cites this paper
• Improved adipose tissue function with initiation of protease inhibitor-only ART

  2016cites this paper
• Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome

  2015cites this paper
• Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs

  2015cites this paper
• Antiretroviral Therapy – Changes of Basic Laboratory Parameters in Hiv-Infected Bulgarian Patients

  2015cites this paper
• Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicity.

  2015cites this paper
• Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma - method-comparison evaluations.

  2014cites this paper
• The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.

  2014cites this paper
• Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients

  2014cites this paper
• PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy.

  2014cites this paper
• Antiretroviral Therapy-Induced Mitochondrial Toxicity: Potential Mechanisms Beyond Polymerase-γ Inhibition

  2014cites this paper
• The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation.

  2013cites this paper
• Physical Fitness in Children Infected with the Human Immunodeficiency Virus: Associations with Highly Active Antiretroviral Therapy

  2013cites this paper
• Premature and accelerated aging: HIV or HAART?

  2013cites this paper
• The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV‐infected patients: a randomized trial

  2013cites this paper
• Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome

  2013cites this paper
• Current treatment methods for combination antiretroviral therapy-induced lipoatrophy of the face

  2013cites this paper
• The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapy.

  2013cites this paper
• Metabolic and mitochondrial effects of antiretroviral drug exposure in pregnancy and postpartum: implications for fetal and future health.

  2013cites this paper
• Central role of mitochondria in drug-induced liver injury

  2012cites this paper
• HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue.

  2012cites this paper
• NRTI Backbone in HIV Treatment

  2012cites this paper
• Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA

  2012cites this paper
• The Effects of Fetal and Childhood Exposure to Antiretroviral Agents

  2012cites this paper
• PharmGKB summary: zidovudine pathway.

  2012cites this paper
• High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells

  2012cites this paper
• Mitochondrial functionalism in HIV-infected children receiving antiretroviral therapy

  2012influential citation
• Stochastic modeling of mitochondrial polymerase gamma replication and novel algorithms to enrich rare disease alleles and detect tumor somatic mutations in deep sequencing data

  2012cites this paper
• Body composition and metabolic changes in HIV-infected patients.

  2012cites this paper
• Thymidine Analogues Suppress Autophagy and Adipogenesis in Cultured Adipocytes

  2012cites this paper
• The Crosstalk Between Bone and Fat in HIV-Infected Patients, with a Focus on Lipodystrophy

  2012cites this paper
• BODY FAT MALDISTRIBUTION AMONG HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS ATTENDING CARE AND TREATMENT CLINICS IN DAR ES SALAAM MUNICIPAL HOSPITALS

  2012cites this paper
• Mitochondrial toxicity in HAART: an overview of in vitro evidence.

  2011cites this paper
• adiposityadults with insulin resistance and central insulin-sensitizing effects of pioglitazone in Exercise training augments the peripheral

  2011cites this paper
• Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.

  2011cites this paper
• CHAPTER 38 – Endocrinology of HIV/AIDS

  2011cites this paper
• Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

  2011cites this paper
• Mitochondrial dysfunction and human immunodeficiency virus infection

  2011cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2011cites this paper
• Combination antiretroviral therapy -associated lipodystrophy : insights into pathogenesis and treatment

  2011cites this paper
• Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition.

  2011cites this paper
• Short communication: decrease in mitochondrial transmembrane potential in peripheral blood mononuclear cells of HIV-uninfected subjects undergoing HIV postexposure prophylaxis.

  2011cites this paper
• Mitochondrial Assessment in Asymptomatic HIV-Infected Paediatric Patients on Haart

  2011cites this paper
• HIV and HAART-Associated Dyslipidemia

  2011cites this paper
• Mitochondrial dysfunction and human immunodeficiency virus infection

  2011cites this paper
• Hyperlactataemia in HIV‐infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)

  2011cites this paper
• Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.

  2011cites this paper
• Title : Impact of Lipodystrophy on the Prevalence and Components of Metabolic Syndrome in HIV-infected patients Running title : HIV-Lipodystrophy and Metabolic Syndrome

  2011cites this paper
• Proteomic Profiling of Adipose Tissue from Zmpste24−/− Mice, a Model of Lipodystrophy and Premature Aging, Reveals Major Changes in Mitochondrial Function and Vimentin Processing*

  2011cites this paper
• Adipose tissue biology and HIV-infection.

  2011cites this paper
• Estudio del sistema musculoesquelético mediante resonancia magnética en la valoración del síndrome de lipodistrofia en pacientes infectados por el virus de la inmunodeficiencia humana

  2011cites this paper
• A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy

  2010cites this paper
• Whole blood mitochondrial DNA depletion in South African HIV-infected children

  2010cites this paper
• Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy.

  2010cites this paper
• Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.

  2010cites this paper
• HIV-associated lipodystrophy: from fat injury to premature aging.

  2010cites this paper
• Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients

  2010cites this paper
• Zidovudine and Lamivudine for HIV Infection.

  2010cites this paper
• Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content.

  2010cites this paper
• Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.

  2010cites this paper
• Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients

  2010influential citation
• Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

  2010cites this paper
• Prolonged Nrf1 overexpression triggers adipocyte inflammation and insulin resistance

  2010cites this paper
• Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment.

  2010cites this paper
• Mitochondrial involvement in drug-induced liver injury.

  2010cites this paper
• Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations.

  2010cites this paper
• Understanding and managing the adverse effects of antiretroviral therapy.

  2010cites this paper
• Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

  2009cites this paper
• Morbidity and mortality in HIV-infected individuals - a shift towards comorbidities.

  2009cites this paper
• How sweet it is? Susceptibility to diabetes mellitus in HIV-1 treatment

  2009cites this paper
• Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.

  2009cites this paper
• Tenofovir-associated bone density loss

  2009cites this paper
• Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders

  2009cites this paper
• Strategies to limit the metabolic complications of treatment for HIV infection

  2009cites this paper
• Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.

  2009cites this paper